Sign In
Buy STVN
$18.53
-0.260 (-1.38%)
At Close: Jun 03, 2026
Stevanato Group S.p.A. (STVN) Q1 2023 Earnings Call Transcript
01:30pm, Saturday, 06'th May 2023
Stevanato Group S.p.A. (NYSE:STVN ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Lisa Miles - Senior Vice President, Investor Relations Franco Stevanato - Executive Chai
As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses Estimates
12:49pm, Thursday, 04'th May 2023
Growth stock Stevanato plunged after first quarter earnings as sales from Covid related services fell; maintained its full year outlook The post As Covid Wanes, Maker Of Glass Vials, Other Medical Pro
Stevanato Group (STVN) Q1 Earnings Lag Estimates
09:07am, Thursday, 04'th May 2023
Stevanato Group (STVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.12 per share a year ago.
Stevanato Group to Present at BofA Securities Healthcare Conference
06:30am, Tuesday, 02'nd May 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue?
10:42am, Tuesday, 18'th Apr 2023
Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023
04:30pm, Monday, 17'th Apr 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group S.p.A. (STVN) Hits Fresh High: Is There Still Room to Run?
10:40am, Thursday, 30'th Mar 2023
Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
06:00am, Tuesday, 14'th Mar 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Surging Earnings Estimates Signal Upside for Stevanato (STVN) Stock
01:32pm, Tuesday, 07'th Mar 2023
Stevanato (STVN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates
12:48pm, Thursday, 02'nd Mar 2023
Stevanato (STVN) delivered earnings and revenue surprises of 18.75% and 9.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023
04:45pm, Thursday, 16'th Feb 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group S.p.A. (STVN) Q3 2022 Earnings Call Transcript
12:16pm, Saturday, 12'th Nov 2022
Stevanato Group S.p.A. (NYSE:STVN ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lisa Miles - SVP Investor Relations Franco Stevanato - Executive Chairman Franco M
ASRT vs. STVN: Which Stock Is the Better Value Option?
12:47pm, Monday, 03'rd Oct 2022
ASRT vs. STVN: Which Stock Is the Better Value Option?
ASRT vs. STVN: Which Stock Should Value Investors Buy Now?
12:43pm, Wednesday, 14'th Sep 2022
ASRT vs. STVN: Which Stock Is the Better Value Option?
Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q2 2022 Results - Earnings Call Transcript
01:50pm, Saturday, 06'th Aug 2022
Stevanato Group S.p.A. (NYSE:STVN ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Lisa Miles - Investor Relations Franco Stevanato - Chairman Franco Moro - Chief Exec
